Found: 70
Select item for more details and to access through your institution.
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5569, doi. 10.1111/dom.15906
- By:
- Publication type:
- Article
Diabetes management in the new millennium using insulin pump therapy.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Continuous glucose monitoring in 2011.
- Published in:
- International Journal of Clinical Practice (Supplement), 2012, v. 66, p. 8, doi. 10.1111/j.1742-1241.2011.02848.x
- By:
- Publication type:
- Article
Non‐adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): Results of a post‐approval observational study.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 2, p. 1, doi. 10.1111/dme.14739
- By:
- Publication type:
- Article
Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1762, doi. 10.1111/dom.14761
- By:
- Publication type:
- Article
Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1148, doi. 10.1111/dom.13205
- By:
- Publication type:
- Article
New Opportunities for Therapeutic Changes With Continuous Glucose Sensing.
- Published in:
- Diabetes Spectrum, 2000, v. 13, n. 3, p. 171
- By:
- Publication type:
- Article
Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Glucommander.
- Published in:
- Diabetes Care, 2005, v. 28, n. 10, p. 2418
- By:
- Publication type:
- Article
Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 10, p. 2361, doi. 10.2337/diacare.28.10.2361
- By:
- Publication type:
- Article
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Efficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise.
- Published in:
- Diabetes Care, 2005, v. 28, n. 8, p. 1922
- By:
- Publication type:
- Article
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII.
- Published in:
- Diabetes Care, 2005, v. 28, n. 3, p. 533
- By:
- Publication type:
- Article
Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2001, v. 24, n. 1, p. 69, doi. 10.2337/diacare.24.1.69
- By:
- Publication type:
- Article
Reduction in Severe Hypoglycemia With Long-Term Continuous-Subcutaneous Insulin Infusion in Type I Diabetes.
- Published in:
- Diabetes Care, 1996, v. 19, n. 4, p. 324, doi. 10.2337/diacare.19.4.324
- By:
- Publication type:
- Article
Effectiveness of V-Go® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study.
- Published in:
- Drugs - Real World Outcomes, 2020, v. 7, n. 1, p. 31, doi. 10.1007/s40801-019-00173-8
- By:
- Publication type:
- Article
Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Transition from IV to SC Insulin with Optimal BG Control Following CV Surgery.
- Published in:
- Diabetes, 2007, v. 56, p. A88
- By:
- Publication type:
- Article
Sensor Augmented Pump Therapy: Results of the First Treat-to-Target Study.
- Published in:
- Diabetes, 2007, v. 56, p. A24
- By:
- Publication type:
- Article
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.
- Published in:
- Pediatric Diabetes, 2023, p. N.PAG, doi. 10.1155/2023/8867625
- By:
- Publication type:
- Article
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 11, p. 1933, doi. 10.1007/s13300-023-01476-4
- By:
- Publication type:
- Article
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 5, p. 883, doi. 10.1007/s13300-023-01400-w
- By:
- Publication type:
- Article
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery.
- Published in:
- Diabetes Care, 2024, v. 47, n. 9, p. 1682, doi. 10.2337/dc24-0838
- By:
- Publication type:
- Article
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
- Published in:
- Diabetes Care, 2023, v. 46, n. 4, p. 742, doi. 10.2337/dc22-1915
- By:
- Publication type:
- Article
Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).
- Published in:
- 2017
- By:
- Publication type:
- journal article
REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 7, p. 1181, doi. 10.2337/dc14-2806
- By:
- Publication type:
- Article
Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702-2709.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes.
- Published in:
- Diabetes Care, 2014, v. 37, n. 10, p. 2746, doi. 10.2337/dc13-0327
- By:
- Publication type:
- Article
Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry.
- Published in:
- Diabetes Care, 2014, v. 37, n. 10, p. 2702, doi. 10.2337/dc14-0303
- By:
- Publication type:
- Article
236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-236-OR
- By:
- Publication type:
- Article
149-OR: Evaluation of the Next Generation 180-Day Long-Term Implantable Eversense CGM System: PROMISE Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-149-OR
- By:
- Publication type:
- Article
96-LB: Glycemic Management over 6 Months with the Omnipod 5 Automated Insulin Delivery System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-96-LB
- By:
- Publication type:
- Article
94-LB: IV Insulin via Glucommander, an Electronic Glycemic Management System (eGMS) Demonstrates Low Rates of Hypoglycemia in Patients with Low Glomerular Filtration Rate (GFR) Compared with Other eGMS.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-94-LB
- By:
- Publication type:
- Article
716-P: Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-716-P
- By:
- Publication type:
- Article
711-P: Glycemic Outcomes for Adult Type 1 Diabetes (T1D) with and without DKA Treated with an Electronic Glycemic Management System.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-711-P
- By:
- Publication type:
- Article